The Complexities of Breast Cancer Desmoplasia

Overview

Journal Breast Cancer Res

Specialty Oncology

Date 2001 Apr 18

PMID 11305947

Citations 80

Authors

R A Walker

Affiliations

Soon will be listed here.

Abstract

The stromal, or 'desmoplastic', responses seen histologically in primary breast carcinomas can vary from being predominantly cellular (fibroblasts/myofibroblasts) with little collagen to being a dense acellular tissue. The mechanisms underlying the stromal response are complex; paracrine activation of myofibroblasts by growth factors is important but the contribution of cytokines/chemokines should not be ignored. A recent xenograft study has proposed that platelet-derived growth factor (PDGF) is the initiator of the desmoplastic response, but this has not been confirmed by (limited) analyses in vivo. Further studies are required to elaborate the mechanisms of the desmoplastic response, to determine its role in breast cancer progression and whether it is the same for all carcinomas.

Citing Articles

CTGF (CCN2): a multifaceted mediator in breast cancer progression and therapeutic targeting.

Ghosh P, Dey A, Nandi S, Majumder R, Das S, Mandal M Cancer Metastasis Rev. 2025; 44(1):32.

PMID: 39945880 DOI: 10.1007/s10555-025-10248-4.

The Role of eHsp90 in Extracellular Matrix Remodeling, Tumor Invasiveness, and Metastasis.

Singh P, Jay D Cancers (Basel). 2024; 16(22).

PMID: 39594828 PMC: 11592750. DOI: 10.3390/cancers16223873.

Length-scale study in deep learning prediction for non-small cell lung cancer brain metastasis.

Zhou H, Lin S, Watson M, Bernadt C, Zhang O, Liao L Sci Rep. 2024; 14(1):22328.

PMID: 39333630 PMC: 11436900. DOI: 10.1038/s41598-024-73428-2.

The multifaceted role of the stroma in the healthy prostate and prostate cancer.

Di Carlo E, Sorrentino C J Transl Med. 2024; 22(1):825.

PMID: 39238004 PMC: 11378418. DOI: 10.1186/s12967-024-05564-2.

Personalized Vascularized Models of Breast Cancer Desmoplasia Reveal Biomechanical Determinants of Drug Delivery to the Tumor.

Offeddu G, Cambria E, Shelton S, Haase K, Wan Z, Possenti L Adv Sci (Weinh). 2024; 11(38):e2402757.

PMID: 39041892 PMC: 11481247. DOI: 10.1002/advs.202402757.

References

Rasmussen B, Rose C, Thorpe S, HOU-JENSEN K, Daehnfeldt J, Palshof T . Histopathological characteristics and oestrogen receptor content in primary breast carcinoma. Virchows Arch A Pathol Anat Histol. 1981; 390(3):347-51. DOI: 10.1007/BF00496564. View

Dvorak H, Dickersin G, Dvorak A, Manseau E, Pyne K . Human breast carcinoma: fibrin deposits and desmoplasia. Inflammatory cell type and distribution. Microvasculature and infarction. J Natl Cancer Inst. 1981; 67(2):335-45. View

Lagace R, Grimaud J, Schurch W, Seemayer T . Myofibroblastic stromal reaction in carcinoma of the breast: variations of collagenous matrix and structural glycoproteins. Virchows Arch A Pathol Anat Histopathol. 1985; 408(1):49-59. DOI: 10.1007/BF00739962. View

Dvorak H . Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med. 1986; 315(26):1650-9. DOI: 10.1056/NEJM198612253152606. View

Dickson R, Kasid A, Huff K, Bates S, Knabbe C, Bronzert D . Activation of growth factor secretion in tumorigenic states of breast cancer induced by 17 beta-estradiol or v-Ha-ras oncogene. Proc Natl Acad Sci U S A. 1987; 84(3):837-41. PMC: 304311. DOI: 10.1073/pnas.84.3.837. View

Horgan K, Jones D, Mansel R . Mitogenicity of human fibroblasts in vivo for human breast cancer cells. Br J Surg. 1987; 74(3):227-9. DOI: 10.1002/bjs.1800740326. View

Peres R, Betsholtz C, Westermark B, Heldin C . Frequent expression of growth factors for mesenchymal cells in human mammary carcinoma cell lines. Cancer Res. 1987; 47(13):3425-9. View

Bronzert D, Pantazis P, Antoniades H, Kasid A, Davidson N, Dickson R . Synthesis and secretion of platelet-derived growth factor by human breast cancer cell lines. Proc Natl Acad Sci U S A. 1987; 84(16):5763-7. PMC: 298943. DOI: 10.1073/pnas.84.16.5763. View

Basset P, Bellocq J, Wolf C, Stoll I, Hutin P, Limacher J . A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas. Nature. 1990; 348(6303):699-704. DOI: 10.1038/348699a0. View

10.

Walker R, Dearing S . Transforming growth factor beta 1 in ductal carcinoma in situ and invasive carcinomas of the breast. Eur J Cancer. 1992; 28(2-3):641-4. DOI: 10.1016/s0959-8049(05)80116-9. View

11.

Ronnov-Jessen L, Petersen O . Induction of alpha-smooth muscle actin by transforming growth factor-beta 1 in quiescent human breast gland fibroblasts. Implications for myofibroblast generation in breast neoplasia. Lab Invest. 1993; 68(6):696-707. View

12.

Walker R, Dearing S, Gallacher B . Relationship of transforming growth factor beta 1 to extracellular matrix and stromal infiltrates in invasive breast carcinoma. Br J Cancer. 1994; 69(6):1160-5. PMC: 1969439. DOI: 10.1038/bjc.1994.228. View

13.

Ellis M, Singer C, Hornby A, Rasmussen A, Cullen K . Insulin-like growth factor mediated stromal-epithelial interactions in human breast cancer. Breast Cancer Res Treat. 1994; 31(2-3):249-61. DOI: 10.1007/BF00666158. View

14.

Ethier S . Growth factor synthesis and human breast cancer progression. J Natl Cancer Inst. 1995; 87(13):964-73. DOI: 10.1093/jnci/87.13.964. View

15.

Ronnov-Jessen L, Petersen O, Bissell M . Cellular changes involved in conversion of normal to malignant breast: importance of the stromal reaction. Physiol Rev. 1996; 76(1):69-125. DOI: 10.1152/physrev.1996.76.1.69. View

16.

Steffen C, Harding P, Bhattacharyya N, Pillai S, Brigstock D . Characterization of cell-associated and soluble forms of connective tissue growth factor (CTGF) produced by fibroblast cells in vitro. Growth Factors. 1998; 15(3):199-213. DOI: 10.3109/08977199809002117. View

17.

de Jong J, van Diest P, van der Valk P, Baak J . Expression of growth factors, growth inhibiting factors, and their receptors in invasive breast cancer. I: An inventory in search of autocrine and paracrine loops. J Pathol. 1998; 184(1):44-52. DOI: 10.1002/(SICI)1096-9896(199801)184:1<44::AID-PATH984>3.0.CO;2-H. View

18.

de Jong J, van Diest P, van der Valk P, Baak J . Expression of growth factors, growth-inhibiting factors, and their receptors in invasive breast cancer. II: Correlations with proliferation and angiogenesis. J Pathol. 1998; 184(1):53-7. DOI: 10.1002/(SICI)1096-9896(199801)184:1<53::AID-PATH6>3.0.CO;2-7. View

19.

Devalaraja M, Richmond A . Multiple chemotactic factors: fine control or redundancy?. Trends Pharmacol Sci. 1999; 20(4):151-6. DOI: 10.1016/s0165-6147(99)01342-5. View

20.

Jones J, Glynn P, Walker R . Expression of MMP-2 and MMP-9, their inhibitors, and the activator MT1-MMP in primary breast carcinomas. J Pathol. 1999; 189(2):161-8. DOI: 10.1002/(SICI)1096-9896(199910)189:2<161::AID-PATH406>3.0.CO;2-2. View